Cancer treatment has seen groundbreaking advancements over the decades,
with therapies becoming increasingly precise and personalized. The book explores
the convergence of biosensing technologies, radiotherapy innovations, and
chemotherapy mechanisms to provide a comprehensive guide for researchers,
clinicians, and students. The book begins by tracing the history and evolution
of Intensity-Modulated Radiotherapy (IMRT) as a sophisticated form of Conformal
Radiotherapy (CFRT). It critically examines IMRT's implementation in clinical
practice, addressing both its strengths and limitations. Key discussions
include whether higher doses improve tumor control and survival, the role of
conformal techniques in mitigating late side effects, and the impact of innovations
like multileaf collimators (MLCs) and volumetric-modulated arc therapy on
precision and safety in IMRT delivery. Shifting to cancer chemotherapy, the
book offers a deep dive into the cellular and tumor microenvironmental
mechanisms underlying treatment efficacy. Topics include chemotherapy-induced
senescence, stochastic variations affecting drug sensitivity, and strategies to
overcome cellular resistance. The role of stroma and vasculature in fostering
chemotherapy resistance and the influence of immunity and inflammation on
treatment outcomes are explored in depth. This book not only highlights the
synergy between advanced radiotherapy and chemotherapy approaches but also
underscores the potential of electrochemical biosensors in enhancing diagnostic
precision and monitoring therapeutic responses. Bridging technological
innovation and clinical insights, this book is an essential resource for
advancing cancer research and treatment.
| DETAILS | |
| AUTHOR'S NAME | Noor Al-Huda Raheem Jabbar Abbas, Abbas Mohammed Jassim Nasser, Sajjad Sami Rahman Hussein, Hiba Maani Aboud Muheisen |
| ISBN | 978-93-95949-39-2 |
| EDITION | First 2024 |
| LANGUAGE | English |
| BINDING | Hardbound & E Book |
| PAGES | 80 |
| PUBLISHER | Perception publishing |
| PRICE | 100 USD ||1495.00 INR |
| Processor | |
| Description | Cancer treatment has seen groundbreaking advancements over the decades, with therapies becoming increasingly precise and personalized. The book explores the convergence of biosensing technologies, radiotherapy innovations, and chemotherapy mechanisms to provide a comprehensive guide for researchers, clinicians, and students. The book begins by tracing the history and evolution of Intensity-Modulated Radiotherapy (IMRT) as a sophisticated form of Conformal Radiotherapy (CFRT). It critically examines IMRT's implementation in clinical practice, addressing both its strengths and limitations. Key discussions include whether higher doses improve tumor control and survival, the role of conformal techniques in mitigating late side effects, and the impact of innovations like multileaf collimators (MLCs) and volumetric-modulated arc therapy on precision and safety in IMRT delivery. Shifting to cancer chemotherapy, the book offers a deep dive into the cellular and tumor microenvironmental mechanisms underlying treatment efficacy. Topics include chemotherapy-induced senescence, stochastic variations affecting drug sensitivity, and strategies to overcome cellular resistance. The role of stroma and vasculature in fostering chemotherapy resistance and the influence of immunity and inflammation on treatment outcomes are explored in depth. This book not only highlights the synergy between advanced radiotherapy and chemotherapy approaches but also underscores the potential of electrochemical biosensors in enhancing diagnostic precision and monitoring therapeutic responses. Bridging technological innovation and clinical insights, this book is an essential resource for advancing cancer research and treatment. |